Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mandana Khalili

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Hepatology (Baltimore, Md.)|January 28, 2010
A glimpse of future hepatitis C virus treatment paradigmsNorah Terrault, Mandana Khalili
Annals of Hepatology|February 12, 2015
Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeuticsSarah Schaeffer, Mandana Khalili
Gastroenterology Clinics of North America|August 25, 2004
Treatment of the hepatitis C virus in patients coinfected with HIVMandana Khalili, Nicole Proietti
Journal of Diabetes|July 24, 2015
Is there a relationship between hepatitis B surface antibody status and diabetes?Mandana Khalili, Arun Sanyal
Hepatology Communications|December 11, 2020
ReplyJesse Powell, Mandana Khalili
Digestive Diseases and Sciences|October 13, 2018
Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety NetMandana Khalili, Robert J Wong
Journal of Clinical Gastroenterology|November 6, 2019
A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net PopulationsRobert J Wong, Mandana Khalili
Personalized Medicine|May 15, 2018
The birth and potential death of IL28B genotyping for hepatitis C therapyAlan Hb Wu, Mandana Khalili
Microbes and Infection|December 7, 2002
Hepatitis C in the setting of HIV co-infectionMandana Khalili, Brian W Behm
Obesity Science & Practice|April 10, 2023
Undiagnosed abnormal alanine transaminase levels in vulnerable populations: Impact of sex, race/ethnicity, and body massRebecca G Kim, Mandana Khalili
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|January 28, 2010
A glimpse of future hepatitis C virus treatment paradigmsNorah Terrault, Mandana Khalili
Annals of Hepatology|February 12, 2015
Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeuticsSarah Schaeffer, Mandana Khalili
Gastroenterology Clinics of North America|August 25, 2004
Treatment of the hepatitis C virus in patients coinfected with HIVMandana Khalili, Nicole Proietti
Journal of Diabetes|July 24, 2015
Is there a relationship between hepatitis B surface antibody status and diabetes?Mandana Khalili, Arun Sanyal
Hepatology Communications|December 11, 2020
ReplyJesse Powell, Mandana Khalili
Digestive Diseases and Sciences|October 13, 2018
Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety NetMandana Khalili, Robert J Wong
Journal of Clinical Gastroenterology|November 6, 2019
A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net PopulationsRobert J Wong, Mandana Khalili
Personalized Medicine|May 15, 2018
The birth and potential death of IL28B genotyping for hepatitis C therapyAlan Hb Wu, Mandana Khalili
Microbes and Infection|December 7, 2002
Hepatitis C in the setting of HIV co-infectionMandana Khalili, Brian W Behm
Obesity Science & Practice|April 10, 2023
Undiagnosed abnormal alanine transaminase levels in vulnerable populations: Impact of sex, race/ethnicity, and body massRebecca G Kim, Mandana Khalili
Pageof 14